IFS
BMY icon

Ifrah Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Ifrah Financial Services’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$377K Buy
6,049
+34
+0.6% +$2.15K 0.1% 139
2026
Q2 		$347K Buy
6,015
+35
+0.6% +$2.01K 0.08% 147
2026
Q1 		$363K Sell
5,980
-189
-3% -$11K 0.1% 134
2025
Q4 		$333K Sell
6,169
-158
-2% -$7.6K 0.09% 146
2025
Q3 		$285K Buy
6,327
+14
+0.2% +$654 0.07% 167
2025
Q2 		$292K Buy
6,313
+91
+1% +$4.47K 0.08% 157
2025
Q1 		$379K Sell
6,222
-159
-2% -$9.27K 0.11% 129
2024
Q4 		$361K Sell
6,381
-101
-2% -$5.64K 0.1% 141
2024
Q3 		$335K Buy
6,482
+236
+4% +$11.1K 0.09% 150
2024
Q2 		$259K Sell
6,246
-279
-4% -$12.5K 0.07% 179
2024
Q1 		$354K Sell
6,525
-4,468
-41% -$228K 0.1% 152
2023
Q4 		$564K Sell
10,993
-477
-4% -$25K 0.17% 99
2023
Q3 		$666K Sell
11,470
-29
-0.3% -$1.78K 0.21% 85
2023
Q2 		$735K Sell
11,499
-113
-1% -$7.58K 0.22% 79
2023
Q1 		$805K Sell
11,612
-734
-6% -$51.8K 0.26% 69
2022
Q4 		$888K Sell
12,346
-291
-2% -$21.9K 0.29% 67
2022
Q3 		$898K Sell
12,637
-117
-0.9% -$8.49K 0.31% 67
2022
Q2 		$982K Sell
12,754
-221
-2% -$16.8K 0.32% 65
2022
Q1 		$948K Buy
12,975
+1,882
+17% +$126K 0.27% 73
2021
Q4 		$692K Buy
11,093
+11
+0.1% +$645 0.19% 101
2021
Q3 		$656K Buy
11,082
+50
+0.5% +$3.29K 0.19% 97
2021
Q2 		$737K Sell
11,032
-291
-3% -$19K 0.21% 87
2021
Q1 		$715K Buy
11,323
+2,995
+36% +$186K 0.22% 90
2020
Q4 		$517K Sell
8,328
-139
-2% -$8.55K 0.17% 101
2020
Q3 		$510K Sell
8,467
-145
-2% -$8.73K 0.18% 86
2020
Q2 		$506K Sell
8,612
-351
-4% -$21K 0.18% 90
2020
Q1 		$500K Buy
8,963
+19
+0.2% +$1.16K 0.21% 83
2019
Q4 		$574K Buy
+8,944
New +$512K 0.2% 92

Other funds holding BMY

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return

Ifrah Financial Services's BMY Position: Q3 2026 in Review

Ifrah Financial Services increased its Bristol-Myers Squibb (BMY) stake by 0.57% in Q3 2026, buying an estimated $2.15K and bringing the position to 6,049 shares worth $377K. The position accounts for 0.1% of the portfolio, ranked #139.

Ifrah Financial Services first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. The position peaked at $982K in Q2 2022. 252 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Ifrah Financial Services held 6,049 shares of Bristol-Myers Squibb worth $377K as of Q3 2026.
  • Ifrah Financial Services bought 34 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.15K.
  • Bristol-Myers Squibb made up 0.1% of Ifrah Financial Services's portfolio in Q3 2026, its #139 holding.
  • Ifrah Financial Services first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
  • Ifrah Financial Services's Bristol-Myers Squibb position peaked at $982K in Q2 2022.
  • 252 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Ifrah Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.